SCHEMBL24587233

SCHEMBL24587233

O[C@@H]([C@H](O)[C@@H](O)COC(c1ccccc1)(c1ccccc1)c1ccccc1)[C@H](O)COC(c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TK1 P04183 2/20 0.48
KIF11 P52732 1/20 0.47
DUT P33316 1/20 0.39
CYP2C9 P11712 2/20 0.38
CYP2C19 P33261 2/20 0.38
ALOX15 P16050 2/20 0.38
TSHR P16473 1/20 0.38
CTSK P43235 3/20 0.37
CYP1A2 P05177 1/20 0.36
ALDH1A1 P00352 2/20 0.36
LMNA P02545 1/20 0.34
HRH4 Q9H3N8 1/20 0.34
GRIN1 Q05586 4/20 0.33
GRIN2A Q12879 4/20 0.33
GRIN2D O15399 3/20 0.33
GRIN2C Q14957 3/20 0.33
GRIN2B Q13224 2/20 0.33
CA1 P00915 2/20 0.33
CASR P41180 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6516985 1.00 TK1 (0.48) TK1KIF11DUTCYP2C9CYP2C19
SCHEMBL10438660 0.93 TK1 (0.44) TK1KIF11DUTCYP2C9CYP2C19
SCHEMBL10772460 0.92 TK1 (0.54) TK1KIF11DUTCYP2C9CYP2C19
SCHEMBL8587208 0.89 TK1 (0.44) TK1KIF11DUTCYP2C9CYP2C19
SCHEMBL5505626 0.88 TK1 (0.41) TK1KIF11DUTCYP2C9CYP2C19
SCHEMBL6667600 0.87 TK1 (0.43) TK1KIF11DUTCYP2C9CYP2C19
SCHEMBL20608703 0.87 KIF11 (0.41) TK1KIF11DUTCYP2C9CYP2C19
SCHEMBL19668111 0.87 KIF11 (0.41) TK1KIF11DUTCYP2C9CYP2C19
SCHEMBL19668110 0.87 KIF11 (0.41) TK1KIF11DUTCYP2C9CYP2C19
SCHEMBL19066253 0.87 KIF11 (0.41) TK1KIF11DUTCYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240065261-A1 PENETRATING CRYOPROTECTION AGENTS AND METHODS OF MAKING AND USING SAME UNIV NEW YORK STATE RES FOUND (US) 2024-02-29 US disclosed
US-20240065261-A1 PENETRATING CRYOPROTECTION AGENTS AND METHODS OF MAKING AND USING SAME UNIV NEW YORK STATE RES FOUND (US) 2024-02-29 US disclosed
WO-2022140458-A1 PENETRATING CRYOPROTECTION AGENTS AND METHODS OF MAKING AND USING SAME THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2022-06-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240065261-A1 PENETRATING CRYOPROTECTION AGENTS AND METHODS OF MAKING AND USING SAME SLC29A1, SLC29A2, SLC43A1 TK1 651/4885KIF11 2146/4885DUT 1298/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.